Athira Pharma is Conducting Clinical Trials of ATH-1017
“ATH-1017 is a fast acting novel approach that may have lasting results. — This treatment may lead to rapid and sustained recovery of memory and function.”
Example mechanism of action video for ATH-1017 in Alzheimer's Disease. The same mechanism and therapeutic potential may apply to Parkinson's Disease Dementia or Dementia with Lewy Bodies.